Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)

BACKGROUND: Acute Coronary Syndromes account for 15% of deaths in the UK, and patients remain at significant risk of re-admission for future complications and death. Pathologically the underlying process of atherosclerosis is driven by inflammatory mechanisms, which are activated in ACS patients. Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Crossman, David C, Morton, Allison C, Gunn, Julian P, Greenwood, John P, Hall, Alistair S, Fox, Keith AA, Lucking, Andrew J, Flather, Marcus D, Lees, Belinda, Foley, Claire E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289802/
https://www.ncbi.nlm.nih.gov/pubmed/18298837
http://dx.doi.org/10.1186/1745-6215-9-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289802/
https://www.ncbi.nlm.nih.gov/pubmed/18298837
http://dx.doi.org/10.1186/1745-6215-9-8

Ejemplares similares